In addition to Foxp3, upregulated expression of Helios [86, 87], PD-1 [88], CD39 [89, 90], Neuropilin-1 [91] and CCR8 [29] have been strongly associated with impaired anti-tumoral responses in BrCa. The gene discussed is ENTPD1; the disease is invasive breast carcinoma.